GW786034
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for GW786034, covering 2011-01-04 to 2017-11-17. Get the full timeline:
Most recent: Clinical Trial Update: Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients [Phase 1]